http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2782010-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a9351a1fd2f7ed6e980c0042e0726c2b
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-36
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-285
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02
filingDate 1998-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd4c73df0a4697209440c18d33b45688
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_acb380d6eb10d75d4f5ea15ffd14f217
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d7a13d6994d651f7e165f9f3084773c
publicationDate 2000-02-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2782010-A1
titleOfInvention NEW USE OF ARSENIC COMPOUND FOR MEGACYO-CYCLARY OR PLAQUETRY LEUKEMIA
abstract The present invention relates to a new use of an apoptotic substance, characterized in that an arsenic compound is used as an apoptotic substance for the preparation of a medicament intended for use in therapeutic with respect to for hyperproliferative megakaryocytic or platelet disorders, said arsenic compound preferably being As2 O3.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8497300-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1166789-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1166789-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026319-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8394422-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004026319-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6703049-B2
priorityDate 1998-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10311
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID518740
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419504914
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ0MUT8
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45933887
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48749
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO62757
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP48750
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11052
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51748
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP04141
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493487
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411932836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419564680
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411318591
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22094277
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ60481
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP28773
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ29118
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID887

Total number of triples: 45.